NR4A1 and cancer: Studies in this laboratory have shown the CDIM compounds that act as functional NR4A1 inverse agonists in cancer cells inhibit TNBC cell and tumor growth and the EC50 values for inhibiting tumor growth in athymic nude mice bearing MDA-MB-231 cells by DIM-3,5 analogs is < 1 mg/kg/day [18].